Sg Americas Securities, LLC Aerie Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$20.8 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$6.37 - $15.23 $335,284 - $801,631	52,635 Added 314.24%	69,385 $1.05 Million
Q2 2022 Jul 29, 2022	BUY	$4.95 - $9.16 $82,912 - $153,430	16,750 New	16,750 $126,000
Q1 2022 Apr 29, 2022	SELL	$5.64 - $9.8 $634,054 - $1.1 Million	-112,421 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$7.02 - $13.33 $188,788 - $358,483	-26,893 Reduced 19.3%	112,421 $789,000
Q3 2021 Nov 01, 2021	BUY	$11.32 - $16.63 $492,725 - $723,854	43,527 Added 45.44%	139,314 $1.59 Million

Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $832,162 - $1.04 Million	54,892 Added 134.23%	95,787 $1.53 Million
Q1 2021 May 13, 2021	SELL	$13.12 - $20.9 $563,556 - $897,738	-42,954 Reduced 51.23%	40,895 $731,000
Q4 2020 Feb 04, 2021	BUY	$9.12 - $14.49 $594,113 - $943,936	65,144 Added 348.27%	83,849 $1.13 Million
Q3 2020 Nov 09, 2020	SELL	$10.46 - $14.46 $14,696 - $20,316	-1,405 Reduced 6.99%	18,705 $220,000
Q2 2020 Jul 20, 2020	SELL	$12.0 - $16.13 $3.28 Million - $4.41 Million	-273,480 Reduced 93.15%	20,110 $297,000
Q1 2020 Apr 30, 2020	BUY	$11.84 - $25.52 $3.41 Million - $7.35 Million	288,028 Added 5178.5%	293,590 $3.96 Million
Q4 2019 Jan 28, 2020	BUY	$17.72 - $25.1 $98,558 - $139,606	5,562 New	5,562 $134,000
Q2 2019 Jul 29, 2019	SELL	$28.97 - $48.21 $244,506 - $406,892	-8,440 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$36.32 - $49.25 $106,708 - $144,696	-2,938 Reduced 25.82%	8,440 $401,000
Q4 2018 Feb 01, 2019	BUY	$33.0 - $60.04 $375,474 - $683,135	11,378 New	11,378 $411,000
Q3 2018 Nov 06, 2018	SELL	$56.15 - $73.9 $95,904 - $126,221	-1,708 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$47.85 - $70.45 $52,443 - $77,213	-1,096 Reduced 39.09%	1,708 $115,000
Q1 2018 May 03, 2018	SELL	$51.15 - $61.0 $487,306 - $581,147	-9,527 Reduced 77.26%	2,804 $152,000
Q4 2017 Jan 24, 2018	SELL	$50.85 - $65.1 $93,767 - $120,044	-1,844 Reduced 13.01%	12,331 $737,000
Q3 2017 Nov 07, 2017	BUY	$48.6 - $60.1 $688,905 - $851,917	14,175	14,175 $689,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account